Qualitative cross-cultural exploration of breast symptoms and impacts associated with hormonal treatments for menopausal symptoms to inform the development of new patient-reported measurement tools

Grants

Funding Acknowledgements

The study was funded by Pfizer Pharmaceuticals and was conducted by Adelphi Values. Rob Arbuckle, Louise Humphrey, Steven Walmsley, Nicola Bonner and Sophi Tatlock are consultants and employees of Adelphi Values (or were at the time the research was conducted). Lucy Abraham, Tara Symonds and Sebastian Mirkin are employees of Pfizer Pharmaceuticals (or were at the time the research was conducted). Lorraine Dennerstein and James A. Simon were engaged as key opinion leaders to provide clinical insight into the research. Editorial support for the manuscript has been provided by the medical writing team at Adelphi Values.